First oral MS drug approved in U.S.Fingolimod (Gilenya, Novartis) offers patients an alternative to injectable therapies. Video: U of T nursing prof to lead home care safety studyDr. Diane Doran awarded $1 million to head research team CDHF, Rexall release new digestive health resource Resource now available for free at all Rexall stores across Canada. U.S. drug shortages seriously impact patient safety Survey reveals healthcare professionals frustrated by recent drug shortages. Helping hands possible for amputee patients The era of composite tissue allotransplantation of the upper extremity is well underway Where there’s a will, there’s a way Two Canadian centres win stroke care honours Calgary, Toronto Rehab earn new accreditation Blocking agent works in ARDS patients Grassroots movement leads surgeons to web-based system Even a little therapy eases depression, anxiety First Previous 2205 2206 2207 2208 2209 Next Last
